Meg=best bio/pharma reporter on planet. Can we add some coverage on promising therapeutics about to go into trial like Ph 2 oral host directed $BSGM drug in combo with $GILD REM with @mayoclinic COVID chairman as PI with ex $CELG CMO &amp; $MRK vaccine head  https://t.co/9KB2jRhbFQ https://t.co/E7TMJV5e5O